MicroRNA-30b-5p functions as a metastasis suppressor in colorectal cancer by targeting Rap1b

Mengjing Fan1, Ximei Ma2, Feifan Wang3

  • 1Biomedical Research Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Cancer Letters
|March 1, 2020
PubMed

Insights

MicroRNA-30b-5p acts as a tumor suppressor in colorectal cancer liver metastasis (CRLM) by inhibiting cell invasion and migration. It targets Rap1b, a protein promoting cell adhesion and mobility, offering a potential therapeutic target for CRLM.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Metastasis Research

Background:

  • Colorectal liver metastasis (CRLM) is a primary cause of mortality in colorectal cancer (CRC) patients.
  • The precise role of microRNA-30b-5p (miR-30b-5p) in CRLM progression remains largely unelucidated.
  • MiR-30b-5p has demonstrated dual roles as an oncogene or tumor suppressor in various cancer types.

Purpose of the Study:

  • To investigate the functional role of miR-30b-5p in colorectal cancer liver metastasis.
  • To identify the molecular targets of miR-30b-5p involved in CRLM progression.
  • To evaluate the therapeutic potential of targeting the miR-30b-5p/Rap1b axis in CRLM.

Main Methods:

  • In vitro assays assessing cell invasion, migration, adhesion, and motility in CRC cell lines (HCT116, LoVo).
  • Western blot analysis to evaluate the expression of epithelial-mesenchymal transition (EMT) and adhesion-related proteins.
  • Validation of Rap1b as a direct target of miR-30b-5p using luciferase reporter assays and rescue experiments.
  • In vivo studies using mouse models to assess the effect of miR-30b-5p and Rap1b on CRLM.
  • Analysis of miR-30b-5p and Rap1b expression in clinical CRC and liver metastasis (LM) tissues.

Main Results:

  • Overexpression of miR-30b-5p significantly suppressed CRC cell invasion, migration, adhesion, and motility.
  • MiR-30b-5p downregulated EMT markers (Zeb1, Snail, vimentin) and adhesion-related proteins (p-paxillin, p-Src).
  • Rap1b was identified as a direct functional target of miR-30b-5p; its overexpression rescued miR-30b-5p-mediated suppression.
  • MiR-30b-5p overexpression inhibited CRLM in vivo, an effect attenuated by Rap1b rescue.
  • MiR-30b-5p was downregulated in clinical CRC and LM tissues, inversely correlated with Rap1b expression.

Conclusions:

  • MiR-30b-5p functions as a tumor suppressor in colorectal cancer liver metastasis by targeting Rap1b.
  • The miR-30b-5p/Rap1b pathway plays a critical role in regulating CRC cell adhesion, migration, and metastasis.
  • Targeting miR-30b-5p or its downstream effector Rap1b represents a promising therapeutic strategy for CRLM.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K